A Comparison of the Additivity of Brinzolamide Ophthalmic Suspension, 1% (Azopt) and Brimonidine Tartrate Ophthalmic Solution, 0.15% (Alphagan P) to Travoprost Ophthalmic Solution, 0.004% (Travatan) in Patients with Elevated IOP on Travoprost.

Project: Research project

Project Details

StatusFinished
Effective start/end date2/1/04 → 9/1/11

Funding

  • Hermann Eye Fund (HEF-042/ Agmt 3/29/04)